Carregant...
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma
The incidence of renal-cell carcinoma has been increasing each year, with nearly one third of new cases diagnosed at advanced or metastatic stage. The advent of targeted therapies for metastatic renal-cell carcinoma (mRCC) has underscored the need to subtype tumors according to tumor-immune expressi...
Guardat en:
| Publicat a: | Clin Genitourin Cancer |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004481/ https://ncbi.nlm.nih.gov/pubmed/30858035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2019.01.017 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|